Lonza Cologne Gmbh

Amaxa Ag

Lonza Cologne Ag

Corinna Thiel

Gregor Siebenkotten

Gudula Riemen

Juliana Helfrich

Elke Lorbach

Meike Weigel

Heike Wessendorf

Michael Nix

Kirsten Rothmann-Cosic

Herbert Mueller-Hartmann

Helmut Brosterhus

Herbert Müller-Hartmann

Ludger Altrogge

Rainer Christine

Dietmar Lenz

Marion Gremse

Kirsten Rothmann

Helmut Brosterbus

Sabine Poppenborg

A method for introducing biologically active molecules into animal or human cells using an electric current includes suspending the cells and dissolving the biologically active molecules in a buffer solution including HEPES and at least 10 mmol&#xd7;1magnesium ions (Mg), the buffer solution having a buffer capacity of at least 20 mmol&#xd7;1&#xd7;pHat a change in the pH from pH 7 to pH 8 and at a temperature of 25&#xb0; C., and an ionic strength of at least 200 mmol&#xd7;1. An electric voltage is applied to the suspension.

Buffer solution for electroporation and a method comprising the use of the same

The invention relates to a novel circuit arrangement for electrotransfection or electrofusion, which enables the transportation of DNA and/or other biologically active molecules to the nucleus of higher eukaryotic cells or the fusion of cells, independent of cell division and with reduced cell mortality.

Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryotic cells using electrical current

A buffer solution for suspending animal or human cells and for dissolving biologically active molecules in order to introduce the biologically active molecules into the cells using electric current. The buffer solution includes at least one of sodium succinate, mannitol and sodium lactobionate. The buffer solution has a buffer capacity of at least 20 mmol*l*pHat a change in the from pH 7 to pH 8 and at a temperature of 25&#xb0; C., and an ionic strength of at least 200 mmol * l.

A method for introducing biologically active molecules into animal or human cells using electric current includes suspending the cells and dissolving the biologically active molecules in a buffer solution which has a buffer capacity of at least 20 mmol&#xd7;l&#xd7;pHand an ionic strength of at least 200 mmol&#xd7;lat a change in the pH from pH 7 to pH 8 and at a temperature of 25&#xb0; C. to form a suspension. The method further includes applying an electric voltage to the suspension so as to introduce the biologically active molecules into animal or human cells.

The invention relates to a buffer solution for suspending animal or human cells and for dissolving biologically active molecules in order to introduce biologically active molecules into cells using an electric current. The inventive buffer solution has a buffering capacity of at least 20 mmol&#xd7;pHand an ionic strength of at least 200 mmol&#xd7;1during a change to the pH value from pH 7 to pH 8 and at a temperature of 25&#xb0; C. The use of a buffer solution of this type allows biologically active molecules to be introduced into animal and human cells with a high degree of transfection efficiency and at the same time a low cell mortality. Different cell types, in particular dormant and actively dividing cells of low activity, can be successfully transfected in the buffer solution.

Growing community of inventors

Kö'ln, Germany

Corinna Thiel